We are live on !
Find out more
First Manhattan Portfolio holdings
AUM
$39.2B
Turnover
13.59%
1-Year Est. Return
21.04%
First Manhattan is an investment management firm founded in 1964 by David Gottesman, and it works mainly for high net worth individuals. Most of the assets it manages are in stocks, which its portfolio managers pick with a cautious, value-oriented approach. The firm also advises private funds focused on the banking industry and on companies that earn most of their revenue in China, along with two ETFs.
This Fund
S&P 500
This Quarter Est. Return
-0.04%
1 Year Est. Return
+21.04%
3 Year Est. Return
+83.94%
5 Year Est. Return
+115.5%
10 Year Est. Return
+416.22%
AUM
$17.4B
AUM Growth
-$305M
(-1.7%)
Cap. Flow
-$266M
Cap. Flow % of AUM
Cap. Flow %
-1.53%
Top 10 Holdings %
Top 10 Hldgs %
41.08%
Holding
1,605
New
59
Increased
159
Reduced
518
Closed
103
Avg Time Held
1.5
years
Top 10 Avg Time Held
1.3
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$167M |
| 2 |
H&R Block
HRB
|
+$114M |
| 3 |
Microsoft
MSFT
|
+$62.9M |
| 4 |
Medtronic
MDT
|
+$47.1M |
| 5 |
Aramark
ARMK
|
+$40.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$74.7M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$66.5M |
| 3 |
United Parcel Service
UPS
|
+$56.9M |
| 4 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$41.9M |
| 5 |
Liberty Media Corporation Series C Common Stock
FWONK
|
+$41.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 36.12% |
| 2 | Healthcare | 12.39% |
| 3 | Miscellaneous | 9.49% |
| 4 | Industrials | 8.64% |
| 5 | Technology | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class A
BRK.A
$1.26T
| $3.45B | 19.89% |
15,874
-119
| -0.7% | -$26.3M |
2013 Q2
7 quarters
|
|
2
Brookfield
BN
$91.5B
| $632M | 3.64% |
50,375,796
-887,645
| -2% | -$11M |
2013 Q2
7 quarters
|
|
3
CVS Health
CVS
$114B
| $388M | 2.24% |
3,761,408
-216,961
| -5% | -$22M |
2013 Q2
7 quarters
|
|
4
Berkshire Hathaway Class B
BRK.B
$1.26T
| $360M | 2.07% |
2,491,400
+4,507
| +0.2% | +$663K |
2013 Q2
7 quarters
|
|
|
5
Microsoft
MSFT
$3.89T
| $333M | 1.92% |
8,180,833
+1,445,012
| +21% | +$62.9M |
2013 Q2
7 quarters
|
|
6
Wells Fargo
WFC
$258B
| $325M | 1.87% |
5,966,302
-62,458
| -1% | -$3.38M |
2013 Q2
7 quarters
|
|
7
AB InBev
BUD
$167B
| $316M | 1.82% |
2,594,070
-37,472
| -1% | -$4.53M |
2013 Q2
7 quarters
|
|
8
American International
AIG
$43B
| $277M | 1.6% |
5,061,752
-76,639
| -1% | -$4.11M |
2013 Q2
7 quarters
|
|
9
Oracle
ORCL
$391B
| $274M | 1.58% |
6,347,254
+319,355
| +5% | +$13.8M |
2013 Q2
7 quarters
|
|
10
Johnson & Johnson
JNJ
$688B
| $265M | 1.52% |
2,631,034
-41,167
| -2% | -$4.19M |
2013 Q2
7 quarters
|
|
11
Apple
AAPL
$5.18T
| $232M | 1.34% |
7,453,492
+100,076
| +1% | +$3.02M |
2013 Q2
7 quarters
|
|
|
12
Zimmer Biomet
ZBH
$19.5B
| $231M | 1.33% |
2,028,856
+1,459,812
| +257% | +$167M |
2013 Q2
7 quarters
|
|
13
RTX Corp
RTX
$268B
| $225M | 1.29% |
3,045,585
-44,253
| -1% | -$3.3M |
2013 Q2
7 quarters
|
|
14
Honeywell
HON
$70.6B
| $211M | 1.22% |
2,251,593
+3,438
| +0.2% | +$315K |
2013 Q2
7 quarters
|
|
|
DISCK
15
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $210M | 1.21% |
7,112,102
-179,870
| -2% | -$5.44M |
2013 Q2
7 quarters
|
|
|
16
H&R Block
HRB
$6.08B
| $208M | 1.2% |
6,484,952
+3,410,706
| +111% | +$114M |
2013 Q2
7 quarters
|
|
|
17
Aramark
ARMK
$14.2B
| $206M | 1.19% |
9,034,304
+1,750,553
| +24% | +$40.1M |
2014 Q2
3 quarters
|
|
18
Perrigo
PRGO
$2.25B
| $195M | 1.12% |
1,179,066
+221,841
| +23% | +$35.4M |
2014 Q1
4 quarters
|
|
19
ConocoPhillips
COP
$168B
| $187M | 1.08% |
3,001,134
-17,696
| -0.6% | -$1.14M |
2013 Q2
7 quarters
|
|
20
Danaher
DHR
$164B
| $170M | 0.98% |
2,973,880
+134,795
| +5% | +$7.73M |
2013 Q2
7 quarters
|
|
|
VIAB
21
DELISTED
Viacom Inc. Class B
VIAB
| $157M | 0.9% |
2,297,682
+54,433
| +2% | +$3.76M |
2013 Q2
7 quarters
|
|
22
Gilead Sciences
GILD
$208B
| $154M | 0.89% |
1,568,713
+6,499
| +0.4% | +$660K |
2013 Q2
7 quarters
|
|
23
Range Resources
RRC
$12.1B
| $152M | 0.88% |
2,927,328
-810,689
| -22% | -$40.2M |
2013 Q2
7 quarters
|
|
24
Ameren
AEE
$31.8B
| $142M | 0.82% |
3,365,184
-156,833
| -4% | -$6.83M |
2013 Q2
7 quarters
|
|
25
IBM
IBM
$234B
| $141M | 0.81% |
919,995
-15,335
| -2% | -$2.33M |
2013 Q2
7 quarters
|
|
Similar funds
VARA
First Manhattan's Q1 2015 Portfolio in Review
As of Q1 2015, First Manhattan held 1,605 positions worth $17.4B, down 1.7% from $17.7B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
First Manhattan's Q1 2015 filing shows 59 new, 159 increased, 518 reduced and 103 closed positions. Its largest new stake was Service Corp International: 1,192,040 shares worth $31.1M. The largest sale was Baxter International, an estimated $74.7M.
By sector, the portfolio is most concentrated in Financials at 36% of assets, down from 37% a quarter earlier, followed by Healthcare and Miscellaneous.
- First Manhattan's largest Q1 2015 buy was Service Corp International: 1,192,040 shares worth $31.1M.
- First Manhattan added most to Zimmer Biomet in Q1 2015, an estimated $167M increase.
- First Manhattan's biggest Q1 2015 reduction was Baxter International, cutting an estimated $74.7M.
- First Manhattan fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $66.5M.
- First Manhattan's ten largest holdings make up 41% of its $17.4B portfolio in Q1 2015.
- First Manhattan opened 59 new positions and closed 103 in Q1 2015.
- First Manhattan's portfolio value fell 1.7% quarter-over-quarter to $17.4B.
Based on First Manhattan's 13F filing for Q1 2015, filed 30 Apr 2015.